Scarica l'app Stockscreener
11.58
3.08%
0.20
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NXTC Giù?
Forum
Previsione
Precedente Chiudi:
$11.38
Aprire:
$11.51
Volume 24 ore:
14,111
Relative Volume:
0.27
Capitalizzazione di mercato:
$39.13M
Reddito:
-
Utile/perdita netta:
$-58.52M
Rapporto P/E:
-5.5407
EPS:
-2.09
Flusso di cassa netto:
$-45.03M
1 W Prestazione:
+2.27%
1M Prestazione:
+11.61%
6M Prestazione:
+2,396%
1 anno Prestazione:
+1,109%
Intervallo 1D:
$10.95
$11.80
Intervallo di 1 settimana:
$10.38
$11.80
Portata 52W:
$0.224
$15.74
Nextcure Inc Stock (NXTC) Company Profile
Nome
Nextcure Inc
Settore
Industria
Telefono
240-399-4900
Indirizzo
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Confronta NXTC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
11.55 | 38.56M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.40 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.53 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.45 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.88 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.69 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-07 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2022-11-04 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2022-03-01 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-03-05 | Aggiornamento | Truist | Hold → Buy |
| 2021-01-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2020-07-16 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-07-13 | Downgrade | ROTH Capital | Buy → Neutral |
| 2020-07-13 | Downgrade | SunTrust | Buy → Hold |
| 2020-06-01 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2020-06-01 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-05-26 | Iniziato | JMP Securities | Mkt Outperform |
| 2020-03-24 | Iniziato | The Benchmark Company | Buy |
| 2020-03-02 | Iniziato | ROTH Capital | Buy |
| 2020-01-13 | Iniziato | SunTrust | Buy |
| 2019-12-05 | Iniziato | Needham | Buy |
| 2019-11-26 | Iniziato | BTIG Research | Buy |
| 2019-07-09 | Iniziato | BofA/Merrill | Buy |
| 2019-06-03 | Iniziato | Morgan Stanley | Overweight |
| 2019-06-03 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Nextcure Inc Borsa (NXTC) Ultime notizie
Analyzing Monte Rosa Therapeutics (NASDAQ:GLUE) and NextCure (NASDAQ:NXTC) - Defense World
Is NextCure Inc. stock a buy on dips2025 Market WrapUp & Stock Market Timing Techniques - Улправда
Breakouts Watch: What margin trends mean for NextCure Inc. stockQuarterly Risk Review & Free Technical Pattern Based Buy Signals - Улправда
NextCure Launches At-The-Market Stock Offering Program - TipRanks
NextCure Enters ATM Offering Agreement - TradingView — Track All Markets
Will NextCure Inc. stock remain a Wall Street favorite2025 Key Highlights & Daily Profit Maximizing Tips - DonanımHaber
Will NextCure Inc. stock maintain growth storyQuarterly Market Summary & Verified Momentum Stock Watchlist - DonanımHaber
What margin trends mean for NextCure Inc. stockJuly 2025 Short Interest & High Return Trade Guides - Улправда
Is NextCure Inc. stock positioned well for digital economyQuarterly Trade Review & Long Hold Capital Preservation Plans - DonanımHaber
Aug Mood: Is NextCure Inc. stock a buy on dipsJuly 2025 Closing Moves & Weekly Market Pulse Updates - Улправда
Swing Trade: Is NextCure Inc. stock a buy on dips2025 Earnings Impact & Weekly Stock Breakout Alerts - Улправда
Death Cross: Can NextCure Inc. stock surprise with earnings upsideJuly 2025 Analyst Calls & Stock Portfolio Risk Management - Улправда
Can NextCure Inc. stock surprise with earnings upsideWeekly Trade Recap & Technical Pattern Based Signals - Улправда
NextCure (NASDAQ:NXTC) Upgraded to “Hold” at Wall Street Zen - Defense World
What sentiment indicators say about NextCure Inc. stockStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
How analysts rate NextCure Inc. stock todayJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - Newser
What is the fair value of NextCure Inc. stock nowJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Will NextCure Inc. stock deliver long term returnsWeekly Profit Report & High Return Trade Guides - Newser
NextCure stock plunges to 52-week low, hits $0.69 - MSN
NextCure files for offering of up to 2.52 million shares of common stock by selling stockholdersSEC filing - marketscreener.com
[S-3] NextCure, Inc. Shelf Registration Statement | NXTC SEC FilingForm S-3 - Stock Titan
Piper Sandler Keeps Their Buy Rating on NextCure (NXTC) - theglobeandmail.com
NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference - The Globe and Mail
NextCure (Nasdaq: NXTC) in fireside chat at Piper Sandler 37th Healthcare Conference - Stock Titan
NextCure Raises $21.5M in Private Placement - MSN
Will NextCure Inc. stock maintain momentum in 2025Trade Entry Summary & Reliable Trade Execution Plans - newser.com
Can NextCure Inc. stock sustain market leadershipQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
FY2025 EPS Estimates for NextCure Boosted by HC Wainwright - Defense World
How currency fluctuations impact NextCure Inc. stockEarnings Overview Report & Precise Buy Zone Tips - newser.com
How NextCure Inc. stock reacts to inflationary pressuresJuly 2025 Drop Watch & Safe Entry Point Identification - newser.com
NextCure Inc. recovery potential after sell offMarket Weekly Review & Fast Entry High Yield Stock Tips - newser.com
Will NextCure Inc. stock gain from lower inflationProfit Target & AI Enhanced Trading Alerts - newser.com
Evaluating NextCure Inc. with trendline analysisEarnings Growth Report & Real-Time Volume Analysis - newser.com
Comparing NextCure Inc. in custom built stock radarsJuly 2025 Sector Moves & Low Volatility Stock Recommendations - newser.com
A activityJuly 2025 Market Mood & Real-Time Volume Trigger Notifications - newser.com
NextCure secures $21.5 million in private placement to extend cash runway - Investing.com Canada
NextCure, Inc. Secures $21.5 Million in Private Placement, Extending Cash Runway into First Half of 2027 - Quiver Quantitative
NextCure (Nasdaq: NXTC) PIPE Extends Runway to 1H 2027 Ahead of 2026 ADC POC Data - Stock Titan
How to integrate NextCure Inc. into portfolio analysis toolsTake Profit & Risk Adjusted Buy/Sell Alerts - newser.com
NextCure, Inc. announced that it has received $21.498209 million in funding from Ikarian Capital, LLC, Squadron Capital Management Llc, Affinity Asset Advisors, LLC, Exome Asset Management LLC - MarketScreener
Nextcure Inc Azioni (NXTC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.02%
3.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):